These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17586012)

  • 1. A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage.
    Suzuki Y; Shibuya M; Satoh S; Sugimoto Y; Takakura K
    Surg Neurol; 2007 Aug; 68(2):126-31; discussion 131-2. PubMed ID: 17586012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study.
    Suzuki Y; Shibuya M; Satoh S; Sugiyama H; Seto M; Takakura K
    Neurol Med Chir (Tokyo); 2008 Jun; 48(6):241-7; discussion 247-8. PubMed ID: 18574328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine.
    Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Zhang Y; Xu B; Zhao K; Wang R; Mao Y; Xu B; Zhang X;
    Neurol Med Chir (Tokyo); 2011; 51(10):679-83. PubMed ID: 22027241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage.
    Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Xu B; Wang R
    Neurol Med Chir (Tokyo); 2006 Sep; 46(9):421-8. PubMed ID: 16998274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of intraarterial administration of fasudil hydrochloride for preventing symptomatic vasospasm after subarachnoid hemorrhage.
    Saito A; Inoue M; Kon H; Imaruoka S; Basaki K; Midorikawa H; Sasaki T; Nishijima M
    Acta Neurochir Suppl; 2015; 120():297-301. PubMed ID: 25366640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid haemorrhage.
    Iwabuchi S; Hayashi M; Yokouchi T; Sato K; Nakayama H; Harashina J; Iwama J; Ishii M; Hiramoto Y; Hirai N; Hirata Y; Saito N; Ito K; Kimura H; Aoki K
    Acta Neurochir Suppl; 2015; 120():167-9. PubMed ID: 25366618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: multicenter cooperative study in Tokyo.
    Kasuya H
    Acta Neurochir Suppl; 2011; 110(Pt 2):165-7. PubMed ID: 21125465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical effect of Fasudil hydrochloride for cerebral vasospasm following subarachnoid hemorrhage.
    Masaoka H; Takasato Y; Nojiri T; Hayakawa T; Akimoto H; Yatsushige H; Toumori H; Miyazaki Y; Honma M
    Acta Neurochir Suppl; 2001; 77():209-11. PubMed ID: 11563288
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage.
    Liu GJ; Wang ZJ; Wang YF; Xu LL; Wang XL; Liu Y; Luo GJ; He GH; Zeng YJ
    Eur J Clin Pharmacol; 2012 Feb; 68(2):131-9. PubMed ID: 21837395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracranial hemorrhage after intra-arterial administration of fasudil for treatment of cerebral vasospasm following subarachnoid hemorrhage: a serious adverse event.
    Ishihara M; Yamanaka K; Nakajima S; Yamasaki M
    Neuroradiology; 2012 Jan; 54(1):73-5. PubMed ID: 21431852
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical investigation of fasudil for the prevention of cerebral vasospasm in extracranial carotid artery stenting.
    Liu J; Yao GE; Zhou HD; Jiang XJ; Xie P
    Cell Biochem Biophys; 2014 Jan; 68(1):185-8. PubMed ID: 23801155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-arterial Administration of Fasudil Hydrochloride for Vasospasm Following Subarachnoid Haemorrhage: Experience of 90 Cases.
    Iwabuchi S; Yokouchi T; Hayashi M; Sato K; Saito N; Hirata Y; Harashina J; Nakayama H; Akahata M; Ito K; Kimura H; Aoki K
    Acta Neurochir Suppl; 2011; 110(Pt 2):179-81. PubMed ID: 21125468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid hemorrhage - analysis of time-density curve with digital subtraction angiography.
    Iwabuchi S; Yokouchi T; Hayashi M; Uehara H; Ueda M; Samejima H
    Neurol Med Chir (Tokyo); 2006 Nov; 46(11):535-9; discussion 540. PubMed ID: 17124368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convulsion during intra-arterial infusion of fasudil hydrochloride for the treatment of cerebral vasospasm following subarachnoid hemorrhage.
    Enomoto Y; Yoshimura S; Yamada K; Iwama T
    Neurol Med Chir (Tokyo); 2010 Jan; 50(1):7-11; discussion 11-2. PubMed ID: 20098018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of selective intra-arterial infusion of fasudil hydrochloride as a treatment of symptomatic vasospasm following SAH.
    Nakamura T; Matsui T; Hosono A; Okano A; Fujisawa N; Tsuchiya T; Indo M; Suzuki Y; Oya S; Chang HS
    Acta Neurochir Suppl; 2013; 115():81-5. PubMed ID: 22890650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of the Rho/Rho-kinase pathway and prevention of cerebral vasospasm by combination treatment with statin and fasudil after subarachnoid hemorrhage in rabbit.
    Naraoka M; Munakata A; Matsuda N; Shimamura N; Ohkuma H
    Transl Stroke Res; 2013 Jun; 4(3):368-74. PubMed ID: 23658597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of fasudil hydrochloride and ozagrel sodium for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Nakashima S; Tabuchi K; Shimokawa S; Fukuyama K; Mineta T; Abe M
    Neurol Med Chir (Tokyo); 1998 Dec; 38(12):805-10; discussion 810-1. PubMed ID: 10063353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial.
    Shibuya M; Suzuki Y; Sugita K; Saito I; Sasaki T; Takakura K; Nagata I; Kikuchi H; Takemae T; Hidaka H
    J Neurosurg; 1992 Apr; 76(4):571-7. PubMed ID: 1545249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
    Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
    J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
    Senbokuya N; Kinouchi H; Kanemaru K; Ohashi Y; Fukamachi A; Yagi S; Shimizu T; Furuya K; Uchida M; Takeuchi N; Nakano S; Koizumi H; Kobayashi C; Fukasawa I; Takahashi T; Kuroda K; Nishiyama Y; Yoshioka H; Horikoshi T
    J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.